Alexion Pharmaceuticals | 3,140.98 / +0.52% |
Date/Time | 03/12 / 00:00 |
Chg. / Chg.(%) | 16.35 / +0.52% |
Bid | - |
Ask | - |
Open | 3,140.98 |
Previous Close | 3,124.63 |
High | 3,140.98 |
Low | 3,140.98 |
Volume [MXN] | - |
Volume [Units] | 282 |
Price fixings | |
ISIN | US0153511094 |
Security | ALXN |
Exchange | Mexico |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 135.10 | ![]() |
|
NASDAQ | 163.6800 | ![]() |
7,307,061 |
Cboe US | 163.70 | ![]() |
498,140 |
IEX | 163.66 | ![]() |
224,820 |
London Inter.. | 164.20 | ![]() |
25,030 |
TradeGate | 136.760 | ![]() |
656 |
Frankfurt | 137.4400 | ![]() |
530 |
Xetra | 137.04 | ![]() |
507 |
gettex | 136.640 | ![]() |
294 |
Vienna Globa.. | 136.98 | ![]() |
154 |
Stuttgart | 136.680 | ![]() |
135 |
Düsseldorf | 136.48 | ![]() |
50 |
Berlin | 130.90 | ![]() |
0 |
München | 131.20 | ![]() |
0 |
Mexico | 3,140.98 | ![]() |
282 |
News
- Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
04/13/2021 / 14:00 - GlobeNewswire - Avenue Therapeutics Announces that the FDA is Still Reviewing Its NDA Resubmission for IV Tramadol
04/13/2021 / 12:30 - GlobeNewswire - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
04/09/2021 / 15:05 - GlobeNewswire - Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
04/09/2021 / 14:00 - GlobeNewswire - Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
04/08/2021 / 13:40 - GlobeNewswire